MedCity Update – July 2015
View this email in your browser


From Dr Eliot Forster, MedCity’s Executive Chair 

You need around 50 professions to get a drug to market, and there is no better place to find that expertise than the UK – that was our main message for MedCity’s flying visit to BIO 2015 in Philadelphia in June. As ever, attending BIO was both an exhilarating and sobering reminder of the size, scale and competitiveness of the global life sciences industry. Talent is global but you’ll search a long time to find the concentration and critical mass of the greater south east – we must make sure we are taking every opportunity to broadcast that message.

We all know that a key ingredient for any commercial success is investment – life sciences businesses are no exception and in the UK we need more. So it was extremely exciting for me to co-host with the Mayor of London’s Office a round-table in June bringing together some of the best brains in the world to come up with real, lasting answers to this funding challenge. More details on that project are below, and discussions are continuing, in particular with the European Investment Bank – I will share updates with you as soon as I can.

Mayor considers ‘megafund’ to boost life sciences investment

The Mayor of London and MedCity are bringing together key figures in industry, finance and research to drive innovative new funding models to tackle structural problems within UK life sciences investment. Amongst options under consideration is the establishment of ‘megafunds’ of up to £10bn to provide the large pools of patient capital needed to develop a crucial tier of mid-sized life sciences companies.
See comment in the Financial Times.
Read more

Healthcare investment trends 2015

Following January’s inaugural Future of Healthcare Investor Forum hosted by the London Stock Exchange and MedCity, an event in June recapped key messages and debated the current and future situation of life sciences investment. 
Read key messages from the event

Boston’s PureTech raises $171m in London

Boston-based PureTech Health has become the latest US life sciences company to float on the London Stock Exchange, raising $171m. MedCity’s Eliot Forster describes the listing as “a success to celebrate” and argues that there are many reasons for a life sciences company to choose London over the USA.
Read more

Cracking the innovation nut

The NHS Confederation and the AHSN Network publishes a briefing paper on the challenges and experiences of the fifteen regional Academic Health Science Networks as they have grappled with diffusing innovation across the NHS. 

Read the paper

Sir Robert Lechler to be new Academy of Medical Sciences President

Executive Director of King’s Health Partners and MedCity Advisory Board member Sir Robert Lechler has been announced as the next President of the Academy of Medical Sciences. Sir Robert will take up the post in December, following Sir John Tooke, Academic Director of UCLPartners and also a member of MedCity’s Advisory Board.
Read more

Illumina chooses Granta for new European HQ 

Genomics company Illumina has signed a deal with BioMed Realty to create a new laboratory building at Cambridgeshire’s Granta Park. The 155,000 square foot research building will be home to its new European HQ.
Read more

Immunocore wins Emerging Star at European Mediscience Awards

Oxford’s Immunocore, now led by MedCity’s Eliot Forster, was named Emerging Star of the Year at the European Mediscience AwardsMedCity for its work targeting T cell receptors. 

Read more

OBN Awards – nominations open

The OBN Annual Awards are now open for entries with a deadline of 31 July. The awards will be announced at an event on 1 October at the Ashmolean Museum, Oxford.  

Enter the awards

EU Health Programme call for proposals

The European Commission has published this year’s calls for proposals for the EU Health Programme, with a total budget of nine million euros. The deadline for proposals is 15 September. 

Find out more

Industrial Biotechnology Catalyst now open

Round 4 of the IB Catalyst, funded by BBSRC, Innovate UK and EPSRC is now open, with closing dates on 12 August and 2 December. 

Find out more

Coming up


NICE Scientific Advice Open Day, 14 July, NICE

Invest Tokyo Seminar 2015 in London, 15 July, UKTI
Data Protection in the Life Sciences Sector, 15 July, One Nucleus 

Breakfast with the BIA – are you investor-ready?
, 16 July, UK BioIndustry Association
Medical Device Regulations Training, 21 October, South East Health Technologies Alliance

Email us to share your event

MedCity was established in April 2014 by the Mayor of London with the capital’s three Academic Health Science Centres – Imperial College Academic Health Centre, King’s Health Partners and UCLPartners.

2 Royal College Street
London NW1 0NH
T: 020 7691 3588

The next edition of MedCity Update will be sent in August 2015.



Copyright © 2015 MedCity. All rights reserved.